Department of Endocrinology and Internal Medicine
Department of Endocrinology and Internal Medicine is the largest department of its kind in Denmark with 7 full professors, 12 associate professors, 42 PhD students and more than 120 peer reviewed publications annually. In addition to a dedication to general internal medicine we cover every aspect of clinical endocrinology.
The department holds a strong position internationally within the fields of diabetes and obesity, calcium metabolic disorders, and pituitary endocrinology. We have a strong tradition for studying diabetic nephropathy.
We are a major clinical department in Denmark for research in obesity (pathophysiology, treatment, and complications) and have for many years been involved in international clinical trials on nutritional means to prevent obesity and its complications. We are one of the main centers for bariatric surgery in Denmark; we have a dedicated clinic for research in and treatment of post-bariatric complications.
Our research within calcium metabolism and metabolic bone diseases includes aetiology, epidemiology, pathophysiology and treatment of primary hyperparathyroidism, familial hypocalciuric hypercalcaemia and hypoparathyroidism. Our international achievements focus on effects of PTH (1-84) treatment in hypoparathyroidism, effects of emerging new drugs in osteoporosis, and effects of dietary modifications on bone health in the elderly. We also aim at improving our understanding of the non-skeletal effects of vitamin D and how to develop sustainable food-based strategies to reduce vitamin D deficiency and improve quality of life of citizens in Europe. We also study rare metabolic bone diseases including osteogenesis imperfecta and hypophosphatemic rickets.
Our department is leading within pituitary endocrinology and the clinical management of patients with pituitary tumours in collaboration with neurosurgeons, neuroradiologists and neuroopthalmologists. Our research in this field focuses on acromegaly and growth hormone deficiency and includes clinical epidemiology, clinical trials, metabolic studies, development of novel assays for measuring components of the GH-IGF axis, and basic research.